Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.
Morrow PK, Wulf GM, Ensor J, Booser DJ, Moore JA, Flores PR, Xiong Y, Zhang S, Krop IE, Winer EP, Kindelberger DW, Coviello J, Sahin AA, Nuñez R, Hortobagyi GN, Yu D, Esteva FJ. Morrow PK, et al. J Clin Oncol. 2011 Aug 10;29(23):3126-32. doi: 10.1200/JCO.2010.32.2321. Epub 2011 Jul 5. J Clin Oncol. 2011. PMID: 21730275 Free PMC article. Clinical Trial.
Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype.
Theriault RL, Litton JK, Mittendorf EA, Chen H, Meric-Bernstam F, Chavez-Macgregor M, Morrow PK, Woodward WA, Sahin A, Hortobagyi GN, Gonzalez-Angulo AM. Theriault RL, et al. Among authors: morrow pk. Clin Breast Cancer. 2011 Oct;11(5):325-31. doi: 10.1016/j.clbc.2011.05.002. Epub 2011 Jul 20. Clin Breast Cancer. 2011. PMID: 21764391 Free PMC article.
Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer.
Moulder S, Moroney J, Helgason T, Wheler J, Booser D, Albarracin C, Morrow PK, Koenig K, Kurzrock R. Moulder S, et al. Among authors: morrow pk. J Clin Oncol. 2011 Jul 1;29(19):e572-5. doi: 10.1200/JCO.2010.34.0604. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21482991 Clinical Trial. No abstract available.
Effect of CYP2D6 polymorphisms on breast cancer recurrence.
Morrow PK, Serna R, Broglio K, Pusztai L, Nikoloff DM, Hillman GR, Fontecha M, Li R, Michaud L, Hortobagyi G, Gonzalez-Angulo AM. Morrow PK, et al. Cancer. 2012 Mar 1;118(5):1221-7. doi: 10.1002/cncr.26407. Epub 2011 Aug 5. Cancer. 2012. PMID: 21823108 Free article.
Effect of age and race on quality of life in young breast cancer survivors.
Morrow PK, Broxson AC, Munsell MF, Basen-Enquist K, Rosenblum CK, Schover LR, Nguyen LH, Hsu L, Castillo L, Hahn KM, Litton JK, Kwiatkowski DN, Hortobagyi GN. Morrow PK, et al. Clin Breast Cancer. 2014 Apr;14(2):e21-31. doi: 10.1016/j.clbc.2013.10.003. Epub 2013 Oct 25. Clin Breast Cancer. 2014. PMID: 24461458 Free PMC article. Review.
53 results